PLAVIX® (clopidogrel bisulfate) recommended as effective cardiovascular risk reduction treatment for patients with established Peripheral Arterial Disease (P.A.D.)

Menu

Media Room Menu

PLAVIX® (clopidogrel bisulfate) recommended as effective cardiovascular risk reduction treatment for patients with established Peripheral Arterial Disease (P.A.D.)

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.